Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University Medical Center Hamburg-Eppendorf, University Hospital in Halle, University Cancer Center Hamburg, TUM Klinikum, Technical University of Munich, Universitätsklinikum Gießen und Marburg, University Hospital Ulm, Onkozentrum Dresden, Institute of Clinical Cancer Research, Krankenhaus Nordwest, München Klinik Neuperlach, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3005197357
